UK’s NICE Says More Evidence Needed for HumiGard

New guidance from the UK’s National Institute for Health and Care Excellence (NICE) says Fisher and Paykel Healthcare’s HumiGard shows promise for preventing hypothermia during abdominal surgery, although there is not enough evidence to support routine use.

HumiGard humidifies and heats carbon dioxide used to fill the peritoneal cavity during laparoscopic abdominal surgery. Its purpose is to avoid problems caused by using dry, cold CO2 gas, including tissue desiccation and intra-operative hypothermia. HumiGard is designed to be used both independently and in addition to other warming measures applied externally, such as forced-air warming.

NICE recommended more research on how much HumiGard costs and whether it can help avoid adverse surgical outcomes.

Read the guidance here: www.fdanews.com/02-22-17-HumiGardguidance.pdf.